Bayer's Study on Darolutamide in Japanese Men with Low-Volume mHSPC
Bayer is conducting an observational study to assess the safety and efficacy of darolutamide combined with ADT and docetaxel in Japanese men with low-volume metastatic hormone-sensitive prostate cancer.